The Alternative 2/1 Schedule of Sunitinib is Superior to the Traditional 4/2 Schedule in Patients With Metastatic Renal Cell Carcinoma: A Meta-analysis
- Resource Type
- Review Article
- Source
- In
Clinical Genitourinary Cancer October 2019 17(5):e847-e859 - Subject
- Language
- ISSN
- 1558-7673